Concepedia

Kazuki Sakamoto

KS

Statistics

Publications

40

Citations

1.6K

H-Index

21

Active since

1987

Affiliations

Taiho Pharmaceutical (Japan)(Current)

University of Tsukuba

Kanazawa University

University of Central Florida

Kishiwada Tokushukai Hospital

Kazuki Sakamoto is an author at Taiho Pharmaceutical (Japan) specializing in medicine, oncology, and molecular oncology.

Publications per year

1987–2023

40

Publications

40

Novel Membrane Transporter OCTN1 Mediates Multispecific, Bidirectional, and pH-Dependent Transport of Organic Cations

H Yabuuchi, Ikumi Tamai, Jun‐ichi Nezu et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 316 citations

, , +12

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe et al. · Oncology Reports · 2014 · 142 citations · Full text

, , +13

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Hiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto et al. · Oncology Reports · 2015 · 109 citations · Full text

, , +17

New method for prevention of bile leakage after hepatic resection

Akira Hayashibe, Kazuki Sakamoto, Masaya Shinbo et al. · Journal of Surgical Oncology · 2006 · 86 citations

, , +13

A high-Tc intrinsic Josephson junction emitter tunable from 0.5 to 2.4 terahertz

Takanari Kashiwagi, Kazuki Sakamoto, Hiroyuki Kubo et al. · Applied Physics Letters · 2015 · 73 citations · Full text

, , +16

1–5 of 40